financetom
Business
financetom
/
Business
/
UK's Assura backs rival's $2.4 billion takeover offer over KKR-Stonepeak bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK's Assura backs rival's $2.4 billion takeover offer over KKR-Stonepeak bid
Jun 22, 2025 11:56 PM

June 23 (Reuters) - British healthcare real estate

investor Assura on Monday recommended rival Primary

Health Properties' ( PHPRF ) new 1.79 billion pounds ($2.4

billion) takeover bid that trumps a lower offer from KKR

and Stonepeak Partners.

Primary Health Properties's ( PHPRF ) latest 53.3 pence per

share bid was higher than KKR-Stonepeak's "best and final" offer

of 52.1 pence tabled earlier this month, and at a 47% premium to

Assura's closing price before KKR-Stonepeak's first approach.

Assura shareholders would get 0.3865 new PHP shares,

12.5 pence in cash, and be entitled to

a special dividend of 0.84 pence per share under the terms

of the latest bid, the companies said.

The private equity firms and PHP have been competing over

Assura for months, gradually sweetening their offers for the

company which manages over 600 healthcare properties and counts

Britain's state-backed National Health Service as a customer.

($1 = 0.7444 pounds)

(Reporting by Shashwat Awasthi in Bengaluru; Editing by Mrigank

Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; COO to Retire
Update: CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; COO to Retire
Nov 11, 2025
05:43 PM EST, 11/11/2025 (MT Newswires) -- (Updates with organizational changes in the headline and the fifth and sixth paragraphs.) CAE (CAE) reported fiscal Q2 adjusted earnings late Tuesday of CA$0.23 ($0.16), down from CA$0.24 a year earlier. Analysts polled by FactSet expected CA$0.20. Revenue for the quarter ended Sept. 30 was CA$1.24 billion, up from CA$1.14 billion a year...
Music streamer Stingray's Q2 revenue beats estimates on higher FAST channel sales
Music streamer Stingray's Q2 revenue beats estimates on higher FAST channel sales
Nov 11, 2025
Overview * Stingray fiscal Q2 revenue grows 21% yr/yr, beating analyst expectations * Adjusted EBITDA for fiscal Q2 beats analyst expectations * Company announces acquisition of TuneIn Holdings to expand digital audio footprint Outlook * Stingray did not provide specific financial guidance for future quarters or full year in press release Result Drivers * FAST CHANNEL SALES - Stingray attributes...
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials
Metagenomi to Advance Hemophilia A Gene Therapy to Clinical Trials
Nov 11, 2025
05:42 PM EST, 11/11/2025 (MT Newswires) -- Metagenomi ( MGX ) plans to advance its MGX-001 gene therapy for Hemophilia A into clinical development after preclinical data showed curative levels of clotting factor activity in non-human primates. A single-dose treatment restored therapeutically relevant levels of factor VIII, a protein essential for blood clotting, with activity ranging from 17% to 81%...
Label maker CCL's Q3 sales beat estimates
Label maker CCL's Q3 sales beat estimates
Nov 11, 2025
Overview * CCL Industries ( CCLLF ) Q3 sales rose 6.3%, beating analyst expectations * Adjusted EPS for Q3 increased 11% yr/yr, reflecting strong operational performance * Company returned C$155.8 mln to shareholders via dividends and share repurchases Outlook * Company expects modest currency translation tailwind for Q4 2025 earnings * Company well-positioned for global expansion with C$1.1 bln cash-on-hand...
Copyright 2023-2026 - www.financetom.com All Rights Reserved